In Type 1 Diabetes a Subset of Anti-Coxsackievirus B4 Antibodies Recognize Autoantigens and Induce Apoptosis of Pancreatic Beta Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Bason, Caterina ^a   Lorini, Renata ^b   Lunardi, Claudio ^a   Dolcino, Marzia ^c   Giannattasio, Alessandro ^b   d'Annunzio, Giuseppe ^b   Rigo, Antonella ^a   Pedemonte, Nicoletta ^c   Corrocher, Roberto ^a   Puccetti, Antonio ^b,c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; AUTOANTIGEN; CALCIUM CHANNEL L TYPE; CELL ANTIGEN; PHOGRIN; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY LIBRARY; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL SPECIFICITY; CELL SURFACE; CHILD; CONTROLLED STUDY; COXSACKIE VIRUS B4; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; EPITOPES; HUMANS; INFANT; INSULIN-SECRETING CELLS; MALE; MICE; VIRAL PROTEINS; YOUNG ADULT;

EID: 84874571737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057729     Document Type: Article

References (59)

1. Eizirik DL, Colli ML, Ortis F, (2009) The role of inflammation in insulitis andbeta cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219-226.
2. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK, (2011) Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33: 9-21.
3. Yeung WC, Rawlinson WD, Craig ME (2011) Enterovirus infection and type I diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342: d35 DOI10.1136/bmj.d35.
4. Stene LC, Rewers M, (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 168: 12-23.
5. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H, (2011) Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 33: 45-55.
6. Oikarinen S, Martiskainen M, Tauriainen S, Huhtala H, Ilonen J, et al. (2011) Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 60: 276-179.
7. Schulte BM, Bakkers J, Lanke KH, Melchers WJ, Westerlaken C, et al. (2010) Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection.Viral Immunol. 23: 99-104.
8. Hober D, Sauter P, (2010) Pathogenesis of type I diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6: 279-289.
9. Oikarinen M, Tauriainen S, Oikarinen S, Honkanen T, Collin P, et al. (2012) Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 61: 687-691.
10. Mercalli A, Lampasona V, Klingel K, Albarello L, Lombardoni C, et al. (2012) No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia 55: 2479-2488.
11. Dotta F, Censini S, van Halteren AG, Marselli L, Masini M, et al. (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 104: 5115-5120.
12. Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, et al. (2004) Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47: 225-239.
13. Grieco FA, Sebastiani G, Spagnuolo I, Patti A, Dotta F, (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function. Clin Exp Immunol 168: 24-29.
14. Ghazarian L, Diana J, Simoni Y, Beaudoin L, Lehuen A (2012) Prevention or acceleration of type 1 diabetes by viruses. Cell Mol Life Sci DOI10.1007/s00018-012-1042-1.
15. Schulte BM, Lanke KH, Piganelli JD, Kers-Rebel ED, Bottino R, et al. (2012) Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 61: 2030-2036.
16. Jaïdane H, Sané F, Hiar R, Goffard A, Gharbi J, et al. (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis. Clin Exp Immunol 168: 39-46.
17. Hober D, Sane F, Jaïdane H, Riedweg K, Goffard A, et al. (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin Exp Immunol 168: 47-51.
18. In't Veld P, (2011) Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets 3: 131-138.
19. Lunardi C, Bason C, Navone R, Millo E, Damonte G, et al. (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6: 1183-1186.
20. Lunardi C, Bason C, Leandri M, Navone R, Lestani M, et al. (2001) Autoantibodies to inner ear and endothelial antigens in Cogan syndrome. Lancet 360: 915-921.
21. Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, et al. (2006) In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 3: e358.
22. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, et al. (2009) Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361: 2135-2142.
23. Puccetti A, Lunardi C, (2010) The role of peptide libraries in the identification of novel autoantigen targets in autoimmune diseases. Discov Med 9: 224-228.
24. American Diabetes Association, (2006) Diagnosis and classification of diabetes mellitus. Diabetes care S29: S43-S49.
25. Wellings DA, Atherton E, (1997) Standard FMOC protocols. Meth Enzymol 289: 44-67.
26. Troiano L, Ferraresi R, Lugli E, Nemes E, Roat E, et al. (2007) Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry. Nat Protoc 2: 2719-2727.
27. Cavalieri E, Rigo A, Bonifacio M, Carcereri de Prati A, Guardalben E, et al. (2011) Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells. J Transl Med 21: 9-45.
28. Pedemonte N, Boido D, Moran O, Giampieri M, Mazzei M, et al. (2007) Structure-activity relationship of 1,4-dihydropyridines as potentiators of the cystic fibrosis transmembrane conductance regulator chloride channel. Mol Pharmacol 72: 197-207.
29. Richer MJ, Horwitz MS, (2009) Coxsackievirus infection as an environmental factor in the etiology of type I diabetes. Autoimmun Rev 8: 601-615.
30. Jaïdane H, Hober D, (2008) Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metabol 34: 537-548.
31. Tuszkiewicz-Misztal E, (1991) Epidemiologic factors and serum antibody titer to Coxsackie B4 virus in patients with type I diabetes. Kinderarztl Prax 59: 88-91.
32. Jaïdane H, Sanè F, Gharbi J, Aouni M, Romond MB, et al. (2009) Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 25: 591-603.
33. Richarson SJ, Willicox A, Bone AJ, Foulis AK, Morgan NG, (2009) The prevalence of enteroviral capsid protein VP1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52: 1143-1151.
34. Wasmeier C, Hutton JC, (1996) Molecular cloning of phogrin, a protein tyrosine phosphatase homologue localized to insulin secretory granule membrane. J Biol Chem 271: 18161-18170.
35. Kubosaki A, Gross S, Miura J, Saeki K, Zhu M, et al. (2004) Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice. Diabetes 53: 1684-1691.
36. Torii S, Saito N, Kawano A, (2009) Gene silencing of phogrin unveils its essential role in glucose-responsive pancreatic beta cell growth. Diabetes 58: 682-692.
37. Torii S, Saito N, Kawano A, Zhao S, Izumi T, et al. (2005) Cytoplasmic transport signal is involved in phogrin targeting and localization to secretory granules. Traffic 6: 1213-1224.
38. Kubosaki A, Nakamura S, Notkins AL, (2006) Dense core vesicle proteins IA-2 and IA2beta metabolic alteration in double knockout mice. Diabetes 54: s46-s51.
39. Torii S, (2009) Expression and function of IA-2 family proteins, unique neuroendocrine-specific protein-tyrosine phosphatases. Endocr J 56: 639-648.
40. Sola-Penna M, Da Silva D, Coelho WS, Marinho-Carvalho MM, Zancan P, (2010) Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism. IUBMB Life 62: 791-6.
41. Coelho WS, Da Silva D, Marinho-Carvalho MM, Sola-Penna M, (2012) Serotonin modulates hepatic 6-phosphofructo-1-kinase in an insulin synergistic manner. Int J Biochem Cell Biol 44: 150-157.
42. Merrins MJ, Bertram R, Sherman A, Satin LS, (2012) Phosphofructo-2-kinase/fructose-2,6-bisphosphatase modulates oscillations of pancreatic islet metabolism. PLoS One 7: e34.
43. Ristow M, Vorgerd M, Möhlig M, Schatz H, Pfeiffer A, (1999) Insulin resistance and impared insulin secretion due to phosphofructo-1-kinase-deficiency in humans. J Mol Med 77: 96-103.
44. Ristow M, Carlqvist H, Hebinck J, (1999) Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes 48: 1557-1561.
45. Yang SN, Berggren PO, (2005) Beta Cell CaV channel regulation in physiology and pathophysiology. Am J Physiol Endocrinol Metab 288: E16-28.
46. Yang SN, Berggren PO, (2006) The Role of Voltage-Gated Calcium Channels in Pancreatic Cell Physiology and Pathophysiology. Endocrine Rev 27: 621-676.
47. Juntti-Berggren L, Refai E, Appelskog I, Andersson M, Imreh G, et al. (2004) Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes. Proc Natl Acad Sci U S A 101: 10090-10094.
48. Wang L, Bhattacharjee A, Zuo Z, Hu F, Honkanen RE, et al. (1999) A low voltage-activated Ca2+ current mediates cytokine-induced pancreatic beta-cell death. Endocrinology 140: 1200-1204.
49. Hell JW, Westenbroek RE, Warner C, Ahlijanian MK, Prystay W, et al. (1993) Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol 123: 949-962.
50. Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW, (2009) Beta cell apoptosis in diabetes. Apoptosis 14: 1389-1404.
51. McKenzie MD, Dudek NL, Mariana L, Chong MM, Trapani JA, et al. (2006) Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. Int Immunol 18: 837-846.
52. Thomas HE, Trapani JA, Kay TW, (2010) The role of perforin and granzymes in diabetes. Cell Death Differ 17: 577-585.
53. Chang I, Cho N, Kim S, Kim JY, Kim E, et al. (2004) Role of calcium in pancreatic islet cell death by IFN-gamma/TNF-alfa. J Immunol 172: 7008-7014.
54. Lee MS, Chang I, Kim S, (2004) Death effectors of beta-cell apoptosis in type 1 diabetes. Mol Genet Metab 83: 82-92.
55. Lablanche S, Cottet-Rousselle C, Lamarche F, Benhamou PY, Halimi S, et al. (2011) Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin. Cell Death Dis 2: e134.
56. Galluzzi L, Zampami N, de La Motte Rouge T, Lemaire C, Brenner C, et al. (2007) Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis 12: 803-813.
57. Colli ML, Nogueira TC, Allagnat F, Cunha DA, Gurzov EN, et al. (2011) Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathog 7: e1002267.
58. Jackson MW, Gordon TP, (2010) A novel impedance-based cellular assay for the detection of anti-calcium channel autoantibodies in type 1 diabetes. J Immunol Methods 361: 31-36.
59. Atsumi T, Chiba H, Yoshioka N, Bucala R, Koike T, (2007) Increased Fructose 2,6-bisphosphate in peripheral blood mononuclear cells of patients with diabetes. Endocr J 54: 517-520.